title: Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
authors.affiliation: Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Danny.Rischin@petermac.org
authors.forename: Danny
authors.initials: D
authors.lastname: Rischin
authors.forename: Richard
authors.initials: R
authors.lastname: Fisher
authors.forename: Lester
authors.initials: L
authors.lastname: Peters
authors.forename: June
authors.initials: J
authors.lastname: Corry
authors.forename: Rodney
authors.initials: R
authors.lastname: Hicks
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000556:secondary; D015687:Cell Hypoxia; D002945:Cisplatin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D006801:Humans; D049268:Positron-Emission Tomography; D011379:Prognosis; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D000077704:Tirapazamine; D014227:Triazines / Q000627:therapeutic use
chemical_list: D011838:Radiation-Sensitizing Agents; D014227:Triazines; D000077704:Tirapazamine; D002945:Cisplatin